Predicting immunity against new pandemic viruses
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.07101E+13
Grant search
Key facts
Disease
COVID-19, OtherStart & end year
20242026Known Financial Commitments (USD)
$0Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr. M van BovenResearch Location
NetherlandsLead Research Institution
Universitair Medisch Centrum UtrechtResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The impact of new pandemic viruses on public health is largely determined by the degree of existing cross immunity in the human population. Such cross immunity is caused by broad T and B cell immune response that determine the severity of the infection. During the recent SARS-COV-2 Pandemie, a prominent genetic association with asymptomatic infection was found, which is attributed to T-cell crusal immunity caused by the seasonal coronaviruses OC43 and HKU1.